We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

165 hedge funds and large institutions have $1.12B invested in Intellia Therapeutics in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 69 increasing their positions, 33 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 33

101% more call options, than puts

Call options by funds: $3.84M | Put options by funds: $1.92M

1.32% more ownership

Funds ownership: 94.85% → 96.17% (+1.3%)

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

1% more funds holding

Funds holding: 164 → 165 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less capital invested

Capital invested by funds: $1.13B → $1.12B (-$11.2M)

Holders
165
Holders Change
+1
Holders Change %
+0.61%
% of All Funds
3.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
69
Reduced
33
Closed
25
Calls
$3.84M
Puts
$1.92M
Net Calls
+$1.93M
Net Calls Change
-$1.26M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$15.4M
2
BlackRock
BlackRock
New York
+$12.4M
3
Goldman Sachs
Goldman Sachs
New York
+$8.64M
4
Morgan Stanley
Morgan Stanley
New York
+$8.48M
5
Millennium Management
Millennium Management
New York
+$6.85M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$8.79M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.79M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.54M
4
O
OrbiMed
New York
-$2.88M
5
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$2.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
Neuberger Berman Group
51
Neuberger Berman Group
New York
$1.25M +$133K +6,385 +11%
AllianceBernstein
52
AllianceBernstein
Tennessee
$1.23M -$27.1K -1,300 -2%
B
53
Bailard
California
$1.2M – – –
Bank of America
54
Bank of America
North Carolina
$1.17M +$707K +33,925 +136%
ECM
55
ExodusPoint Capital Management
New York
$1.09M +$330K +15,841 +41%
CSS
56
Cubist Systematic Strategies
Connecticut
$928K -$282K -13,541 -22%
New York State Common Retirement Fund
57
New York State Common Retirement Fund
New York
$914K – – –
IP
58
Intellectus Partners
California
$908K +$952K +45,650 New
EGM
59
Engineers Gate Manager
New York
$903K +$947K +45,438 New
ACM
60
AlphaCrest Capital Management
New York
$901K +$945K +45,300 New
TI
61
Trexquant Investment
Connecticut
$890K +$206K +9,871 +28%
SFI
62
Susquehanna Fundamental Investments
Pennsylvania
$876K +$919K +44,055 New
WM
63
WS Management
Florida
$835K – – –
SG Americas Securities
64
SG Americas Securities
New York
$787K +$108K +5,170 +15%
Skandinaviska Enskilda Banken (SEB)
65
Skandinaviska Enskilda Banken (SEB)
Sweden
$787K +$806K +38,678 +4,331%
TD Asset Management
66
TD Asset Management
Ontario, Canada
$772K +$89.7K +4,300 +12%
HighTower Advisors
67
HighTower Advisors
Illinois
$756K +$484K +23,204 +156%
Victory Capital Management
68
Victory Capital Management
Texas
$743K +$780K +37,385 New
Mirae Asset Global Investments
69
Mirae Asset Global Investments
South Korea
$738K +$246K +11,795 +47%
Deutsche Bank
70
Deutsche Bank
Germany
$694K -$1.06M -50,889 -59%
Jane Street
71
Jane Street
New York
$631K +$429K +20,584 +184%
LPL Financial
72
LPL Financial
California
$613K +$91.9K +4,406 +17%
CAM
73
Cresset Asset Management
Illinois
$599K +$301K +14,428 +92%
Barclays
74
Barclays
United Kingdom
$597K +$459 +22 +0.1%
AIG
75
American International Group
New York
$596K +$65.8K +3,158 +12%
1 2
3
4 5

NTLA Hedge Fund Activity: Q3 2020 in Review

165 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q3 2020, worth a combined $1.12B — down 1% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new NTLA positions and 25 closed out — a net gain of 1 holder — while 69 added to existing stakes and 33 trimmed.

The largest buyer was State Street, adding an estimated $15.4M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $8.79M sold.

  • 165 institutional investors held Intellia Therapeutics (NTLA) as of Q3 2020, up from 164 in Q2 2020.
  • Funds reported $1.12B of Intellia Therapeutics stock for Q3 2020, down 1% quarter-over-quarter.
  • 26 funds opened new Intellia Therapeutics positions in Q3 2020 and 25 closed out, a net change of +1 holder.
  • The largest Intellia Therapeutics buyer in Q3 2020 was State Street, an estimated $15.4M added.
  • The largest Intellia Therapeutics seller in Q3 2020 was Avidity Partners Management, an estimated $8.79M sold.

Based on aggregated 13F filings for Q3 2020.